Prevention of Gram-Negative Pneumonia

Allan M. Parham; James H. Tenney; Thomas W. Feeley; Gary C. du Moulin; John Hedley-Whyte; Leonard S. Bushnell; John P. Gilbert; David S. Feingold

doi:10.1056/NEJM197512112932417

Prevention of Gram-Negative Pneumonia

Allan M. Parham, James H. Tenney, Thomas W. Feeley, Gary C. du Moulin, John Hedley-Whyte, Leonard S. Bushnell, John P. Gilbert, David S. Feingold

Anesthesiology & PeriOperative Medicine

Research output: Contribution to journal › Letter › peer-review

1 Scopus citations

Abstract

To the Editor: It is of considerable interest that the most active group of researchers in the field of antibiotic prophylaxis against acquired respiratory infections have decided that “continuous use of polymixin B aerosol appears to be a dangerous form of therapy,” (Feeley TW, duMoulin GC, Hedley-Whyte J, et al: Aerosol polymixin and pneumonia. N Engl J Med 293:471–475, 1975). We are indebted to the Beth Israel group for their exhaustive study of polymixin B prophylaxis and the fine data that they have accumulated. Unfortunately, the conclusion that they have drawn is not supported by their study, and the statistics….

Original language	English (US)
Pages (from-to)	1262-1263
Number of pages	2
Journal	New England Journal of Medicine
Volume	293
Issue number	24
DOIs	https://doi.org/10.1056/NEJM197512112932417
State	Published - Dec 11 1975

ASJC Scopus subject areas

General Medicine

Access to Document

10.1056/NEJM197512112932417

Cite this

@article{eb0bce8091c74a3c9396bd4eebf5f929,

title = "Prevention of Gram-Negative Pneumonia",

abstract = "To the Editor: It is of considerable interest that the most active group of researchers in the field of antibiotic prophylaxis against acquired respiratory infections have decided that “continuous use of polymixin B aerosol appears to be a dangerous form of therapy,” (Feeley TW, duMoulin GC, Hedley-Whyte J, et al: Aerosol polymixin and pneumonia. N Engl J Med 293:471–475, 1975). We are indebted to the Beth Israel group for their exhaustive study of polymixin B prophylaxis and the fine data that they have accumulated. Unfortunately, the conclusion that they have drawn is not supported by their study, and the statistics….",

author = "Parham, {Allan M.} and Tenney, {James H.} and Feeley, {Thomas W.} and {du Moulin}, {Gary C.} and John Hedley-Whyte and Bushnell, {Leonard S.} and Gilbert, {John P.} and Feingold, {David S.}",

year = "1975",

month = dec,

day = "11",

doi = "10.1056/NEJM197512112932417",

language = "English (US)",

volume = "293",

pages = "1262--1263",

journal = "New England Journal of Medicine",

issn = "0028-4793",

publisher = "Massachussetts Medical Society",

number = "24",

}

TY - JOUR

T1 - Prevention of Gram-Negative Pneumonia

AU - Parham, Allan M.

AU - Tenney, James H.

AU - Feeley, Thomas W.

AU - du Moulin, Gary C.

AU - Hedley-Whyte, John

AU - Bushnell, Leonard S.

AU - Gilbert, John P.

AU - Feingold, David S.

PY - 1975/12/11

Y1 - 1975/12/11

N2 - To the Editor: It is of considerable interest that the most active group of researchers in the field of antibiotic prophylaxis against acquired respiratory infections have decided that “continuous use of polymixin B aerosol appears to be a dangerous form of therapy,” (Feeley TW, duMoulin GC, Hedley-Whyte J, et al: Aerosol polymixin and pneumonia. N Engl J Med 293:471–475, 1975). We are indebted to the Beth Israel group for their exhaustive study of polymixin B prophylaxis and the fine data that they have accumulated. Unfortunately, the conclusion that they have drawn is not supported by their study, and the statistics….

AB - To the Editor: It is of considerable interest that the most active group of researchers in the field of antibiotic prophylaxis against acquired respiratory infections have decided that “continuous use of polymixin B aerosol appears to be a dangerous form of therapy,” (Feeley TW, duMoulin GC, Hedley-Whyte J, et al: Aerosol polymixin and pneumonia. N Engl J Med 293:471–475, 1975). We are indebted to the Beth Israel group for their exhaustive study of polymixin B prophylaxis and the fine data that they have accumulated. Unfortunately, the conclusion that they have drawn is not supported by their study, and the statistics….

UR - http://www.scopus.com/inward/record.url?scp=0016849662&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0016849662&partnerID=8YFLogxK

U2 - 10.1056/NEJM197512112932417

DO - 10.1056/NEJM197512112932417

M3 - Letter

C2 - 171571

AN - SCOPUS:0016849662

SN - 0028-4793

VL - 293

SP - 1262

EP - 1263

JO - New England Journal of Medicine

JF - New England Journal of Medicine

IS - 24

ER -

Prevention of Gram-Negative Pneumonia

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this